Yahoo
NasdaqCM - Nasdaq Real Time Price USD

CervoMed Inc. (CRVO)

3.6300 +0.5300 (+17.10%)
As of 3:04:38 PM EDT. Market Open.
Chart Range Bar
Loading chart for CRVO
  • Previous Close 3.1000
  • Open 3.0500
  • Bid 2.8300 x 200
  • Ask 4.6400 x 200
  • Day's Range 3.0500 - 3.9298
  • 52 Week Range 2.1300 - 13.1300
  • Volume 1,517,316
  • Avg. Volume 5,538,773
  • Market Cap (intraday) 33.609M
  • Beta (5Y Monthly) -4.54
  • PE Ratio (TTM) --
  • EPS (TTM) -3.2800
  • Earnings Date (est.) Aug 13, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 19.50

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

www.cervomed.com

15

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 7/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CRVO
54.05%
S&P 500 (^GSPC)
9.59%

1-Year Return

CRVO
38.79%
S&P 500 (^GSPC)
21.04%

3-Year Return

CRVO
27.54%
S&P 500 (^GSPC)
68.57%

5-Year Return

CRVO
93.28%
S&P 500 (^GSPC)
73.66%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -7.96M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-8M
-6M
-4M
-2M
0

Analyst Insights

View More

Analyst Price Targets

9.00
19.50 Average
3.6300 Current
27.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/23/2026
Analyst HC Wainwright & Co.
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 25 -> 25

Statistics

View More

Valuation Measures

Annual
As of 6/30/2026
  • Market Cap

    28.79M

  • Enterprise Value

    15.87M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.71

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -72.41%

  • Return on Equity (ttm)

    -132.76%

  • Revenue (ttm)

    2.09M

  • Net Income Avi to Common (ttm)

    -30.04M

  • Diluted EPS (ttm)

    -3.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.92M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -16.3M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

3.6300 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: